We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
(+9.2%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$89.2M |
| 2 |
Flutter Entertainment
FLUT
|
+$43.9M |
| 3 |
Okta
OKTA
|
+$32.1M |
| 4 |
Chewy
CHWY
|
+$31.8M |
| 5 |
Coinbase
COIN
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$91M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$75.5M |
| 3 |
Amazon
AMZN
|
+$71.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$71.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$68.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.83% |
| 2 | Financials | 13.86% |
| 3 | Consumer Discretionary | 10.91% |
| 4 | Healthcare | 9.41% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
ArriVent BioPharma
AVBP
$1.4B
| $739K | ﹤0.01% |
33,954
-3,189
| -9% | -$66.2K |
|
|
TDAY
2327
USA Today Co
TDAY
$1.01B
| $735K | ﹤0.01% |
205,296
-3,179
| -2% | -$10.7K |
|
2328
Zevra Therapeutics
ZVRA
$664M
| $733K | ﹤0.01% |
83,221
+8,636
| +12% | +$70.1K |
|
2329
Hyster-Yale Materials Handling
HY
$614M
| $733K | ﹤0.01% |
18,430
+1,206
| +7% | +$48K |
|
2330
Qfin Holdings
QFIN
$1.53B
| $732K | ﹤0.01% |
16,882
-5,916
| -26% | -$247K |
|
2331
Caledonia Mining Corp
CMCL
$439M
| $731K | ﹤0.01% |
37,857
-601
| -2% | -$9.41K |
|
2332
Ericsson
ERIC
$33.4B
| $731K | ﹤0.01% |
86,158
+88
| +0.1% | +$723 |
|
2333
Graham Corp
GHM
$1.33B
| $731K | ﹤0.01% |
14,755
+4,257
| +41% | +$158K |
|
2334
LifeMD
LFMD
$167M
| $730K | ﹤0.01% |
53,589
+4,281
| +9% | +$40.4K |
|
2335
TETRA Technologies
TTI
$1.29B
| $729K | ﹤0.01% |
216,947
+468
| +0.2% | +$1.36K |
|
|
MTSR
2336
DELISTED
Metsera Inc
MTSR
| $728K | ﹤0.01% |
25,580
+6,475
| +34% | +$161K |
|
2337
CNB Financial Corp
CCNE
$1.04B
| $728K | ﹤0.01% |
31,828
+1,590
| +5% | +$34.9K |
|
2338
Mineralys Therapeutics
MLYS
$2.31B
| $725K | ﹤0.01% |
53,596
+14,235
| +36% | +$206K |
|
2339
Oric Pharmaceuticals
ORIC
$1.42B
| $725K | ﹤0.01% |
71,431
-17,322
| -20% | -$116K |
|
2340
Hallador Energy
HNRG
$743M
| $724K | ﹤0.01% |
45,740
+8,133
| +22% | +$126K |
|
2341
Rush Enterprises Class B
RUSHB
$9.18B
| $723K | ﹤0.01% |
13,773
+305
| +2% | +$16.6K |
|
2342
Hippo Holdings
HIPO
$868M
| $721K | ﹤0.01% |
25,811
-2,372
| -8% | -$58.4K |
|
2343
Anterix
ATEX
$1.74B
| $718K | ﹤0.01% |
27,998
+11,615
| +71% | +$340K |
|
|
EU
2344
enCore Energy
EU
$221M
| $716K | ﹤0.01% |
250,479
-27,738
| -10% | -$49.9K |
|
|
LENZ
2345
LENZ Therapeutics
LENZ
$145M
| $714K | ﹤0.01% |
24,363
+6,396
| +36% | +$174K |
|
2346
Lloyds Banking Group
LYG
$90B
| $712K | ﹤0.01% |
167,519
+1,114
| +0.7% | +$4.43K |
|
2347
Ribbon Communications
RBBN
$372M
| $708K | ﹤0.01% |
176,592
+23,409
| +15% | +$84.4K |
|
2348
Fortis
FTS
$28.7B
| $707K | ﹤0.01% |
14,805
-393
| -3% | -$18.7K |
|
2349
Peapack-Gladstone Financial
PGC
$822M
| $706K | ﹤0.01% |
25,006
-69
| -0.3% | -$1.9K |
|
2350
Iovance Biotherapeutics
IOVA
$2.95B
| $706K | ﹤0.01% |
410,495
+21,314
| +5% | +$53K |
|
Similar funds
RhumbLine Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
- RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
- RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
- RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
- RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
- RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.